Humalog Injection, Solution
Product Images NDC 50090-4488

87 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 87 technical images submitted to the FDA as part of the official labeling for Humalog (NDC 50090-4488). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Humalog 5sec Clock

Humalog 5sec Clock
An instructional diagram showing a timer icon with a 5-second countdown, indicating a duration of 5 seconds.*
FDA Label Image

Humalog Qr

Humalog Qr
Packaging label for HUMALOG Insulin lispro injection, 100 units/mL, 3 mL cartridge. The label shows instructions on cartridge placement for a reusable delivery device. The labeler is A-S Medication Solutions. The image includes a two-step guide with diagrams for loading and inserting the cartridge into the delivery device.*
FDA Label Image

Figure 1 (Humalog F001 V3)

Figure 1 (Humalog F001 V3)
A line graph comparing blood glucose levels (mg/dL) over time (minutes) for Humalog and Humulin R, each with 10 subjects and a mean dose of 15.4 units. The graph shows trends in glucose levels up to 480 minutes after dosing.*
FDA Label Image

Figure 2 (Humalog F003 V2)

Figure 2 (Humalog F003 V2)
A line graph comparing serum free insulin concentrations over time for Humalog and Humulin R injections, showing insulin levels (mU/L) on the vertical axis and time in minutes on the horizontal axis. The graph includes data from 10 subjects per group with mean dosing indicated.*
FDA Label Image

Humalog Inj Sites V1

Humalog Inj Sites V1
An anatomical diagram illustrating preferred injection sites for HUMALOG (insulin lispro) injection solution. The front view highlights the abdomen and upper thigh areas, while the back view highlights the lower back and upper buttocks areas suitable for subcutaneous injection.*
FDA Label Image

Figure (Humalog Jr Ifu 1 V1)

Figure (Humalog Jr Ifu 1 V1)
Humalog Junior KwikPen insulin lispro injection 100 units per mL solution in a disposable prefilled pen. The pen has a gray body with a white and orange label showing the brand and type. It includes a dial on one end for dose setting and a removable cap.*
FDA Label Image

Humalog Jr Ifu 10 V2

Humalog Jr Ifu 10 V2
HUMALOG 100 IU/mL insulin lispro injection solution vial partial label view showing a measurement scale marked at 0.5 units. The image displays the vial window and a gray cap, indicating the product is for intravenous and subcutaneous use, labeled by A-S Medication Solutions.*
FDA Label Image

Humalog Jr Ifu 11 V2

Humalog Jr Ifu 11 V2
An illustration showing a close-up of a medication pen dial with dosage markings 8 and 9 visible. A red arrow points upwards, indicating the direction to turn or adjust the dial, likely demonstrating how to set or increase the dose for injection.*
FDA Label Image

Humalog Jr Ifu 12 V2

Humalog Jr Ifu 12 V2
An instructional illustration showing a close-up view of an injection pen with a numeric dose indicator window displaying doses from 3 to 5 and a red arrow pointing to the number 4, demonstrating dose selection or adjustment for a medication pen.*
FDA Label Image

Humalog Jr Ifu 13 V2

Humalog Jr Ifu 13 V2
An illustration showing a close-up view of a syringe scale marked in units from 0 to 11, with a red arrow pointing at the 11-unit mark on the scale, likely indicating dosage measurement for an injection.*
FDA Label Image

Humalog Jr Ifu 14 V3

Humalog Jr Ifu 14 V3
An instructional illustration showing a hand administering an injection into the abdomen area by pinching the skin and inserting the needle at an angle. The image demonstrates the proper technique for a subcutaneous injection.*
FDA Label Image

Humalog Jr Ifu 15 V3

Humalog Jr Ifu 15 V3
An illustration showing a close-up of a syringe barrel with a visible dose measurement window indicating units from 0 to 1 in increments of 0.5. The image highlights precise dosing for an injectable solution, relevant for products like Humalog insulin lispro injection.*
FDA Label Image

Humalog Jr Ifu 16 V3

Humalog Jr Ifu 16 V3
An instructional illustration showing a hand holding an insulin syringe or pen, with the cap being removed by pulling it away as indicated by a red arrow. The image demonstrates the step of uncapping the injection device prior to administration.*
FDA Label Image

Humalog Jr Ifu 17 V3

Humalog Jr Ifu 17 V3
An instructional illustration showing a hand holding a syringe, with a red ribbon or strip wrapped around the needle area, possibly indicating a step or feature related to the HUMALOG insulin lispro injection. The image highlights proper handling or usage technique of the injection syringe.*
FDA Label Image

Humalog Jr Ifu 18 V3

Humalog Jr Ifu 18 V3
An instructional illustration showing how to remove the cap from a pen injector device for HUMALOG insulin lispro injection, solution. The image features the pen with the cap on the left, an arrow indicating the direction for cap removal, and the pen body with dose window visible on the right.*
FDA Label Image

Figure (Humalog Jr Ifu 2 V1)

Figure (Humalog Jr Ifu 2 V1)
An instructional illustration showing the parts of the HUMALOG Junior KwikPen insulin injection device, including the pen cap, cartridge holder, label, dose indicator, dose window, dose knob, rubber seal, and plunger. It also depicts pen needle components such as the outer needle shield, inner needle shield, needle, and paper tab, with a separate view of the dose knob.*
FDA Label Image

Humalog Jr Ifu 3 V2

Humalog Jr Ifu 3 V2
An instructional illustration showing the technique for removing the cap from a needle. The image depicts a needle with a cap being pulled off in the direction indicated by a left-pointing red arrow.*
FDA Label Image

Figure (Humalog Jr Ifu 4 V1)

Figure (Humalog Jr Ifu 4 V1)
An instructional illustration showing a hand twisting the cap off a vial or pen-like device, indicated by a red curved arrow suggesting the direction of rotation. This image likely demonstrates preparation steps for an injection solution.*
FDA Label Image

Figure (Humalog Jr Ifu 5 V1)

Figure (Humalog Jr Ifu 5 V1)
An instructional diagram illustrating the twisting of a cap onto or off of a vial or syringe nozzle, indicated by a red arrow showing the direction of rotation.*
FDA Label Image

Figure (Humalog Jr Ifu 6 V1)

Figure (Humalog Jr Ifu 6 V1)
An instructional diagram showing proper disposal of needle shields for HUMALOG insulin lispro injection. The image advises to keep the outer needle shield and to throw away the inner needle shield after use, indicating needle handling steps for safe injection practices.*
FDA Label Image

Humalog Jr Ifu 7 V2

Humalog Jr Ifu 7 V2
An instructional illustration showing a close-up of a dose window on an injection pen with a red arrow pointing to the dose counter, indicating how to view or adjust the insulin dose on the device.*
FDA Label Image

Humalog Jr Ifu 8 V2

Humalog Jr Ifu 8 V2
An instructional illustration showing a hand holding a syringe and flicking the top end to mix or remove air bubbles from the liquid inside before injection.*
FDA Label Image

Humalog Jr Ifu 9 V2

Humalog Jr Ifu 9 V2
An instructional illustration showing a hand holding a syringe with a liquid injection. A zoomed-in circle highlights a drop of liquid at the syringe needle tip, and a red arrow points upward from the syringe plunger, indicating the action to expel air or liquid to the needle tip before injection.*
FDA Label Image

Primary Structure (Humalog Structure V1)

Primary Structure (Humalog Structure V1)
Chemical structure diagram of insulin lispro, showing the amino acid sequences of the A-chain and B-chain connected by disulfide bonds. The structure illustrates the peptide chains with labeled amino acids and their positions.*
FDA Label Image

Humalog Tp Ifu 1 V1

Humalog Tp Ifu 1 V1
HUMALOG Tempo Pen insulin lispro injection 100 units/mL cartridge with a mostly blue body and label. Label indicates single patient use and includes red and white text areas. The pen cap is a darker maroon color. The product is manufactured by A-S Medication Solutions.*
FDA Label Image

Humalog Tp Ifu 11 V1

Humalog Tp Ifu 11 V1
An instructional illustration showing a hand holding a pen injector administering an injection into the abdomen, which is exposed through a raised shirt. The image demonstrates the injection technique for a subcutaneous dose.*
FDA Label Image

Humalog Tp Ifu 12 V1

Humalog Tp Ifu 12 V1
The image shows a partial view of a Humalog injection solution pen labeled with insulin lispro 100 IU/mL. The pen features a visible dose window displaying numbers and a purple dial at the end for dose adjustment. The product is provided by A-S Medication Solutions.*
FDA Label Image

Humalog Tp Ifu 13 V2

Humalog Tp Ifu 13 V2
An instructional diagram showing assembly or preparation of an insulin injection pen device for HUMALOG (Insulin lispro) 100 units/mL. The image depicts a pen with a removable blue cap being pulled off to expose the dosage dial or injection mechanism.*
FDA Label Image

Humalog Tp Ifu 2 V1

Humalog Tp Ifu 2 V1
Illustration showing the parts of the Humalog Tempo Pen injection device and its pen needle components. Labeled parts include the pen cap with cap clip, rubber seal, cartridge holder, plunger, pen body with Humalog label, dose indicator, dose window, and dose knob. Additionally, pen needle parts are depicted separately, including outer needle shield, inner needle shield, needle, and paper tab, noting that needles are not included.*
FDA Label Image

Humalog Tp Ifu 3 V2

Humalog Tp Ifu 3 V2
An instructional diagram showing the detachment of a blue pen-like device from a clear vial or container, indicated by a red arrow pointing left. The image likely illustrates a step in preparing an injection, relevant to administration of HUMALOG insulin lispro injection solution.*
FDA Label Image

Humalog Tp Ifu 4 V1

Humalog Tp Ifu 4 V1
An instructional diagram showing a close-up view of a syringe with dosage markings labeled 1, 2, and 4. A red arrow points to the plunger, indicating direction, likely demonstrating how to adjust or administer the dose.*
FDA Label Image

Humalog Tp Ifu 5 V2

Humalog Tp Ifu 5 V2
An instructional illustration showing a hand holding a syringe labeled HUMALOG with a close-up inset of the syringe's dose knob. The image highlights how to adjust the dose knob on the insulin lispro injection device.*
FDA Label Image

Humalog Tp Ifu 6 V1

Humalog Tp Ifu 6 V1
An illustration depicting a medication vial with a visible label window showing a number counter, likely indicating the dose amount. The vial has a blue body and a maroon cap, suggesting a focus on dose measurement for injection purposes.*
FDA Label Image

Humalog Tp Ifu 7 V1

Humalog Tp Ifu 7 V1
An instructional illustration showing a close-up view of a dosage window on a device, likely an insulin pen, with a red arrow pointing upward to indicate adjusting or setting the dose between 6 and 10 units. The image includes a hand holding the device, demonstrating dose selection.*
FDA Label Image

Humalog Tp Ifu 8 V1

Humalog Tp Ifu 8 V1
Illustration showing a close-up view of the dose selector on a Humalog insulin lispro injection pen. The visible part includes a numeric dose display window and a red arrow indicator showing the selected units to be administered by subcutaneous or intravenous injection.*
FDA Label Image

Humalog Tp Ifu 9 V1

Humalog Tp Ifu 9 V1
Illustration showing the numeric scale of an insulin pen dose window, with a close-up on dosage numbers ranging from 2 to 26 units, highlighting the medication dose selection feature.*
FDA Label Image

Humalog U100 Ifu 1 V3

Humalog U100 Ifu 1 V3
The image shows a Humalog KwikPen insulin lispro injection pen with a blue body. The label includes the proprietary name Humalog KwikPen, the generic name insulin lispro injection, and a note stating for single patient use only. The pen includes a dosage selector visible on the right side.*
FDA Label Image

Humalog U100 Ifu 10 V2

Humalog U100 Ifu 10 V2
An instructional diagram showing the dial window of a dosing device for HUMALOG insulin lispro injection, solution 100 IU/mL by A-S Medication Solutions. The dial window displays dose increments, illustrating how to set the dose for intravenous or subcutaneous administration.*
FDA Label Image

Humalog U100 Ifu 11 V2

Humalog U100 Ifu 11 V2
Illustration showing a hand holding and adjusting a dosing pen for HUMALOG insulin lispro injection, solution 100 [iU]/mL. The image focuses on the dose selector with visible numbers 8 and 10, and a red arrow indicating the direction to turn the dial to select the dose.*
FDA Label Image

Humalog U100 Ifu 12 V2

Humalog U100 Ifu 12 V2
An illustration showing the dosage window of an insulin pen with a red arrow pointing at the number 12 on the dose selector.*
FDA Label Image

Humalog U100 Ifu 13 V2

Humalog U100 Ifu 13 V2
Illustration showing a close-up view of the dose selector window on a HUMALOG (insulin lispro) injection pen. The visible dial displays dose numbers with an arrow pointing at the selected dose between 24 and 26 units, indicating dose adjustment functionality.*
FDA Label Image

Figure (Humalog U100 Ifu 16 V1)

Figure (Humalog U100 Ifu 16 V1)
An instructional illustration showing a hand administering an injection with a syringe into the abdominal area of a person. The image emphasizes correct injection technique and site, focusing on subcutaneous injection for medication delivery.*
FDA Label Image

Figure (Humalog U100 Ifu 18 V1)

Figure (Humalog U100 Ifu 18 V1)
An instructional illustration showing a hand holding a Humalog insulin lispro injection pen with the cap being removed by pulling it off. The pen displays a dosage scale up to 120 units, emphasizing preparation for subcutaneous injection.*
FDA Label Image

Figure (Humalog U100 Ifu 19 V1)

Figure (Humalog U100 Ifu 19 V1)
An instructional illustration showing a hand holding a syringe with a twist mechanism being demonstrated, likely related to the preparation or use of an injectable medication solution.*
FDA Label Image

Humalog U100 Ifu 2 V3

Humalog U100 Ifu 2 V3
An instructional diagram showing labeled parts of the Humalog KwikPen insulin injection device, including the cap clip, pen clip, rubber seal, cartridge holder, plunger, label, pen body, dose indicator, dose window, and dose knob. It also depicts pen needle parts (not included) such as outer needle shield, inner needle shield, needle, and paper tab, along with a separate view of the dose knob.*
FDA Label Image

Humalog U100 Ifu 20 V3

Humalog U100 Ifu 20 V3
An instructional diagram illustrating the removal of a blue cap from a syringe containing an injection solution. The syringe is marked with measurement indicators. The arrow indicates the direction to pull off the cap from the syringe.*
FDA Label Image

Humalog U100 Ifu 3 V2

Humalog U100 Ifu 3 V2
An instructional illustration showing the removal of a blue cap from a white insulin injection pen by pulling it off towards the left, indicated by a red arrow pointing leftward.*
FDA Label Image

Figure (Humalog U100 Ifu 4 V1)

Figure (Humalog U100 Ifu 4 V1)
An instructional illustration showing a hand holding a vial while another hand removes the vial's cap by twisting it off. A red curved arrow emphasizes the direction to twist the cap for removal.*
FDA Label Image

Figure (Humalog U100 Ifu 5 V1)

Figure (Humalog U100 Ifu 5 V1)
Illustration showing how to remove or peel off a protective seal or cover from the tip of an injection vial or syringe, indicated by a red arrow guiding the peeling direction.*
FDA Label Image

Figure (Humalog U100 Ifu 6 V1)

Figure (Humalog U100 Ifu 6 V1)
An instructional illustration showing how to handle the needle shield for an injection device, including keeping the outer needle shield and disposing of the inner needle shield. Arrows indicate the direction for handling each component.*
FDA Label Image

Humalog U100 Ifu 7 V2

Humalog U100 Ifu 7 V2
An illustration showing a close-up of a dosing window on an insulin delivery device with dose markings (1, 2, 4) visible. A red arrow points upward to the right, indicating the direction to adjust or read the dose setting.*
FDA Label Image

Humalog U100 Ifu 8 V2

Humalog U100 Ifu 8 V2
An instructional illustration showing a person handling a syringe filled with medication, with one hand holding the syringe and the other hand pushing a finger on the plunger. The syringe barrel has visible volume markings.*
FDA Label Image

Humalog U100 Ifu 9 V2

Humalog U100 Ifu 9 V2
An instructional diagram showing a hand holding a syringe filled with medication and an enlarged circular inset indicating a close-up view of the syringe plunger and barrel markings. A red arrow points to the syringe plunger, suggesting movement or action.*
FDA Label Image

Figure (Humalog U200 Ifu 1 V3)

Figure (Humalog U200 Ifu 1 V3)
HUMALOG KwikPen insulin lispro injection pen featuring a gray body with a dose selector window displaying a dial set to 0 and a needle cap with a red-pink ring. The label includes instructions indicating single-patient use and a dose scale up to 200 units. Manufactured by A-S Medication Solutions.*
FDA Label Image

Figure (Humalog U200 Ifu 10 V2)

Figure (Humalog U200 Ifu 10 V2)
An instructional illustration showing a person preparing an injection syringe with a vial labeled HUMALOG. The image highlights the needle inserted into the vial's rubber stopper and an arrow indicating pushing liquid into the syringe, demonstrating proper medication drawing technique.*
FDA Label Image

Humalog U200 Ifu 11 V1

Humalog U200 Ifu 11 V1
An illustration of an insulin syringe used for subcutaneous injection. The marked graduations on the barrel show dose increments up to 10 units, commonly used for measuring insulin doses like HUMALOG 100 units/mL injection.*
FDA Label Image

Figure (Humalog U200 Ifu 12 V2)

Figure (Humalog U200 Ifu 12 V2)
An instructional illustration showing a hand holding an insulin pen cartridge with a red arrow pointing upward, indicating the removal or lifting action for the cartridge or its cap.*
FDA Label Image

Figure (Humalog U200 Ifu 13 V3)

Figure (Humalog U200 Ifu 13 V3)
An illustration showing a close-up view of a graduated scale on an insulin pen or syringe, highlighting the measurement markings for insulin dosing. A red arrow points specifically to the marking for 12 units, indicating how to read the dose setting on the device.*
FDA Label Image

Figure (Humalog U200 Ifu 14 V2)

Figure (Humalog U200 Ifu 14 V2)
An instructional diagram showing a close-up of an insulin pen dose window with dosage markings from 2 to 26 units. The red arrow points specifically to the 26-unit mark, indicating the selected dose. The visual aids in dose selection for injection using the insulin pen.*
FDA Label Image

Figure (Humalog U200 Ifu 16 V2)

Figure (Humalog U200 Ifu 16 V2)
An instructional illustration showing a person injecting medication into the abdominal area. The image depicts the use of an insulin syringe for subcutaneous injection near the waistline.*
FDA Label Image

Figure (Humalog U200 Ifu 19 V3)

Figure (Humalog U200 Ifu 19 V3)
An instructional illustration showing a hand removing the cap from a pen injector device, which is likely used for administering the medication HUMALOG (insulin lispro) injection solution 100 units/mL. The pen unit is depicted with a caution label on it.*
FDA Label Image

Figure (Humalog U200 Ifu 2 V1)

Figure (Humalog U200 Ifu 2 V1)
Warning label with a yellow background and black text stating: 'DO NOT TRANSFER TO A SYRINGE SEVERE OVERDOSE CAN RESULT' accompanied by a black exclamation mark inside a triangle symbol.*
FDA Label Image

Figure (Humalog U200 Ifu 20 V3)

Figure (Humalog U200 Ifu 20 V3)
An instructional illustration showing a hand holding a HUMALOG (insulin lispro) 100 unit/mL injection pen, with a red arrow indicating twisting or turning the pen cap or dial mechanism. The image appears to guide the user on how to prepare or adjust the injection pen prior to use.*
FDA Label Image

Figure (Humalog U200 Ifu 21 V3)

Figure (Humalog U200 Ifu 21 V3)
An instructional illustration showing a step in the preparation or administration of an injection solution. The image depicts a vial or cartridge with a red arrow pointing to the left, indicating removal or insertion direction for a component, likely the cap or stopper, associated with the medication Humalog (insulin lispro) injection, 100 [iU]/mL.*
FDA Label Image

Figure (Humalog U200 Ifu 3 V3)

Figure (Humalog U200 Ifu 3 V3)
Illustration diagram showing the parts of the Humalog KwikPen injection device and its pen needle components. Labeled parts of the KwikPen include the pen cap, cap clip, rubber seal, cartridge holder with warning label, plunger, label with product name, pen body, dose window, dose indicator, and dose knob. The pen needle parts shown include outer needle shield, inner needle shield, needle, and paper tab; needles are not included.*
FDA Label Image

Figure (Humalog U200 Ifu 4 V2)

Figure (Humalog U200 Ifu 4 V2)
Illustration showing the removal of a protective cap from a pen-style injector. An arrow indicates the direction to pull the cap off, exposing the injection needle or cartridge inside.*
FDA Label Image

Figure (Humalog U200 Ifu 5 V2)

Figure (Humalog U200 Ifu 5 V2)
An instructional illustration showing a hand gripping a vial cap and twisting it counterclockwise to remove the cap. The image uses an arrow to indicate the removal direction. This likely demonstrates how to open a vial before use.*
FDA Label Image

Figure (Humalog U200 Ifu 6 V2)

Figure (Humalog U200 Ifu 6 V2)
An instructional illustration showing a close-up view of a syringe or vial with a red arrow indicating to rotate or remove the cap from the tip. The image suggests a preparation step for an injection, likely related to the HUMALOG insulin lispro injection solution.*
FDA Label Image

Figure (Humalog U200 Ifu 7 V2)

Figure (Humalog U200 Ifu 7 V2)
An instructional diagram showing proper disposal of the needle shield for HUMALOG (insulin lispro injection). It advises to keep the outer needle shield, depicted with an arrow, and to throw away the inner needle shield after use, illustrated by an image of the injection pen with the inner shield removed.*
FDA Label Image

Figure (Humalog U200 Ifu 8 V2)

Figure (Humalog U200 Ifu 8 V2)
An instructional diagram showing a close-up view of a dosage adjustment mechanism, featuring a numbered scale with positions 0, 1, and 2 and a red arrow pointing upward toward a dark shaded rectangular area, indicating a step or direction for adjusting the setting.*
FDA Label Image

Figure (Humalog U200 Ifu 9 V2)

Figure (Humalog U200 Ifu 9 V2)
An instructional illustration showing a hand holding a prefilled syringe labeled HUMALOG 100 units/mL. The image demonstrates gently tapping or flicking the syringe barrel to remove air bubbles before injection.*
FDA Label Image

Figure (Humalog Vial Ifu 1 V5)

Figure (Humalog Vial Ifu 1 V5)
HUMALOG 100 units/mL injection solution vial containing insulin lispro. The label displays the brand name HUMALOG prominently and shows a rubber stopper under a protective cap at the vial top. The product is by A-S Medication Solutions, suitable for intravenous and subcutaneous administration.*
FDA Label Image

Figure (Humalog Vial Ifu 10)

Figure (Humalog Vial Ifu 10)
An instructional illustration showing two hands drawing liquid into a syringe from a vial. The syringe scale is visible, marked with numeric increments from 10 to 40. An upward arrow indicates the motion of pulling the syringe plunger to fill the syringe with liquid.*
FDA Label Image

Figure (Humalog Vial Ifu 11)

Figure (Humalog Vial Ifu 11)
An instructional illustration showing a hand holding a vial and another hand holding a syringe. The syringe needle is being inserted into the vial, indicated by an arrow pointing from the vial towards the syringe needle.*
FDA Label Image

Humalog Vial Ifu 12 V2

Humalog Vial Ifu 12 V2
An illustration showing the front and back views of a human body with highlighted areas indicating preferred injection sites. These include the abdomen, upper thighs on the front view, and the outer upper buttocks on the back view, relevant for subcutaneous administration of injectable medication.*
FDA Label Image

Figure (Humalog Vial Ifu 13)

Figure (Humalog Vial Ifu 13)
An instructional line drawing illustrating the subcutaneous injection technique. It shows a hand holding a syringe and injecting into the lower abdominal area just below the waistline, with an arrow indicating the injection site.*
FDA Label Image

Figure (Humalog Vial Ifu 14)

Figure (Humalog Vial Ifu 14)
An instructional illustration showing a person injecting solution into the abdomen area using a syringe. The image emphasizes the angle and placement for subcutaneous injection.*
FDA Label Image

Figure (Humalog Vial Ifu 15)

Figure (Humalog Vial Ifu 15)
An instructional line drawing showing a person injecting a syringe into the abdominal area, indicating the subcutaneous injection technique commonly used for insulin administration.*
FDA Label Image

Humalog Vial Ifu 2 V3

Humalog Vial Ifu 2 V3
An instructional diagram showing a syringe with labeled parts including the needle shield, needle, plunger tip, syringe body marked with unit measurements, and plunger. The image highlights an example dose of 20 units shown at the plunger tip, illustrating how to measure the dose on the syringe scale.*
FDA Label Image

Figure (Humalog Vial Ifu 3)

Figure (Humalog Vial Ifu 3)
An instructional illustration showing a hand holding a vial with the other hand removing the vial cap by lifting it upwards. The vial appears to be intended for injection use, consistent with medication preparation or administration steps.*
FDA Label Image

Figure (Humalog Vial Ifu 4)

Figure (Humalog Vial Ifu 4)
An instructional illustration showing a hand holding a small vial and using the thumb and forefinger of the other hand to remove the vial's cap. The image likely demonstrates how to prepare a vial of injectable medication, specifically for HUMALOG (Insulin lispro) injection.*
FDA Label Image

Figure (Humalog Vial Ifu 5)

Figure (Humalog Vial Ifu 5)
An instructional illustration showing the proper technique for inserting and holding a syringe. The main image depicts hands holding a syringe with an arrow indicating a downward motion, suggesting injection or fluid withdrawal. An inset shows a close-up of the syringe barrel with measurement markings from 10 to 40 units.*
FDA Label Image

Figure (Humalog Vial Ifu 6)

Figure (Humalog Vial Ifu 6)
An instructional illustration showing a hand holding a vial and another hand inserting a syringe needle into the vial, indicating the process of drawing medication from the vial into the syringe for injection.*
FDA Label Image

Figure (Humalog Vial Ifu 7)

Figure (Humalog Vial Ifu 7)
An instructional illustration showing a hand holding a syringe and drawing medication from a vial, with an arrow indicating the correct technique for pulling the plunger.*
FDA Label Image

Figure (Humalog Vial Ifu 8)

Figure (Humalog Vial Ifu 8)
An instructional diagram showing a hand holding a vial while drawing liquid into a syringe. An arrow indicates the downward pressure applied to the vial as the syringe is filled. A close-up inset shows the syringe barrel marked with measurement units up to 40 units.*
FDA Label Image

Figure (Humalog Vial Ifu 9)

Figure (Humalog Vial Ifu 9)
An instructional illustration showing hands drawing liquid from a vial into a syringe. No text or branding is visible in the image.*
FDA Label Image

Label Image (Lbl500904488)

Label Image (Lbl500904488)
Label for HUMALOG Insulin Lispro Injection, 100 units per mL, in a 10 mL vial. The label includes the NDC 50090-4488-0 and states storage instructions to refrigerate and not freeze. The product is distributed by A-S Medication Solutions, Libertyville, Illinois.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.